Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future Management (Companion Faculty Lecture)
Research To Practice | Oncology Videos
00:00
Emerging Targets and Therapeutic Modalities
Strosberg highlights DLL3, CEACAM6, CAR‑T, radioactives, and bispecifics as expanding treatment options for NECs.
Play episode from 25:25
Transcript
